IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $239 | +6.2% | 50 | 0.0% | 0.00% | – |
Q2 2022 | $225 | -5.5% | 50 | 0.0% | 0.00% | – |
Q1 2022 | $238 | -35.8% | 50 | 0.0% | 0.00% | – |
Q4 2021 | $371 | +30.6% | 50 | 0.0% | 0.00% | – |
Q3 2021 | $284 | -13.9% | 50 | 0.0% | 0.00% | – |
Q2 2021 | $330 | -18.5% | 50 | 0.0% | 0.00% | – |
Q1 2021 | $405 | +25.4% | 50 | 0.0% | 0.00% | – |
Q4 2020 | $323 | +79.4% | 50 | 0.0% | 0.00% | – |
Q3 2020 | $180 | -21.7% | 50 | 0.0% | 0.00% | – |
Q2 2020 | $230 | +34.5% | 50 | 0.0% | 0.00% | – |
Q1 2020 | $171 | -32.9% | 50 | 0.0% | 0.00% | – |
Q4 2019 | $255 | +110.7% | 50 | 0.0% | 0.00% | – |
Q3 2019 | $121 | +11.0% | 50 | 0.0% | 0.00% | – |
Q2 2019 | $109 | -19.9% | 50 | 0.0% | 0.00% | – |
Q1 2019 | $136 | -43.3% | 50 | 0.0% | 0.00% | – |
Q4 2018 | $240 | -49.4% | 50 | 0.0% | 0.00% | – |
Q3 2018 | $474 | -2.7% | 50 | 0.0% | 0.00% | – |
Q2 2018 | $487 | -7.4% | 50 | 0.0% | 0.00% | – |
Q1 2018 | $526 | +63.9% | 50 | 0.0% | 0.00% | – |
Q4 2017 | $321 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |